Log in

Relevant bibliographies by topics / Tobacco use Treatment Victoria / Journal articles

Journal articles on the topic 'Tobacco use Treatment Victoria'

To see the other types of publications on this topic, follow the link: Tobacco use Treatment Victoria.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Tobacco use Treatment Victoria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Jackson, Melissa A., Amanda L. Brown, Amanda L. Baker, Gillian S. Gould, and Adrian J. Dunlop. "The Incentives to Quit tobacco in Pregnancy (IQuiP) protocol: piloting a financial incentive-based smoking treatment for women attending substance use in pregnancy antenatal services." BMJ Open 9, no. 11 (November 2019): e032330. http://dx.doi.org/10.1136/bmjopen-2019-032330.

Full text

Abstract:

IntroductionWhile tobacco smoking prevalence is falling in many western societies, it remains elevated among high-priority cohorts. Rates up to 95% have been reported in women whose pregnancy is complicated by other substance use. In this group, the potential for poor pregnancy outcomes and adverse physical and neurobiological fetal development are elevated by tobacco smoking. Unfortunately, few targeted and effective tobacco dependence treatments exist to assist cessation in this population. The study will trial an evidence-based, multicomponent tobacco smoking treatment tailored to pregnant women who use other substances. The intervention comprises financial incentives for biochemically verified abstinence, psychotherapy delivered by drug and alcohol counsellors, and nicotine replacement therapy. It will be piloted at three government-based, primary healthcare facilities in New South Wales (NSW) and Victoria, Australia. The study will assess the feasibility and acceptability of the treatment when integrated into routine antenatal care offered by substance use in pregnancy antenatal services.Methods and analysisThe study will use a single-arm design with pre–post comparisons. One hundred clients will be recruited from antenatal clinics with a substance use in pregnancy service. Women must be <33 weeks’ gestation, ≥16 years old and a current tobacco smoker. The primary outcomes are feasibility, assessed by recruitment and retention and the acceptability of addressing smoking among this population. Secondary outcomes include changes in smoking behaviours, the comparison of adverse maternal outcomes and neonatal characteristics to those of a historical control group, and a cost-consequence analysis of the intervention implementation.Ethics and disseminationProtocol approval was granted by Hunter New England Human Research Ethics Committee (Reference 17/04/12/4.05), with additional ethical approval sought from the Aboriginal Health and Medical Research Council of NSW (Reference 1249/17). Findings will be disseminated via academic conferences, peer-reviewed publications and social media.Trial registration numberAustralia New Zealand Clinical Trial Registry (Ref: ACTRN12618000576224).

APA, Harvard, Vancouver, ISO, and other styles

2

Guydish, Joseph, Kwinoja Kapiteni, Thao Le, Barbara Campbell, Erika Pinsker, and Kevin Delucchi. "Tobacco use and tobacco services in California substance use treatment programs." Drug and Alcohol Dependence 214 (September 2020): 108173. http://dx.doi.org/10.1016/j.drugalcdep.2020.108173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Leone, Frank T., Sarah Evers-Casey, Mary A. Mulholland, and David P. L. Sachs. "Integrating Tobacco Use Treatment Into Practice." Chest 149, no. 2 (February 2016): 568–75. http://dx.doi.org/10.1378/chest.15-0441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rigotti, Nancy A. "Treatment of Tobacco Use and Dependence." New England Journal of Medicine 346, no. 7 (February 14, 2002): 506–12. http://dx.doi.org/10.1056/nejmcp012279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Shelley, Donna, Deanna Jannat-Khah, and Mark Wolff. "Tobacco-use treatment in dental practice." Journal of the American Dental Association 142, no. 6 (June 2011): 592–96. http://dx.doi.org/10.14219/jada.archive.2011.0229.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kalkhoran, Sara, Neal L. Benowitz, and Nancy A. Rigotti. "Prevention and Treatment of Tobacco Use." Journal of the American College of Cardiology 72, no. 9 (August 2018): 1030–45. http://dx.doi.org/10.1016/j.jacc.2018.06.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Miranda, John. "Tobacco use in the treatment trenches." Alcoholism & Drug Abuse Weekly 32, no. 17 (April 24, 2020): 5–6. http://dx.doi.org/10.1002/adaw.32702.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

McCuistian, Caravella, Kwinoja Kapiteni, Thao Le, Jessica Safier, Kevin Delucchi, and Joseph Guydish. "Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds." Journal of Substance Abuse Treatment 135 (April 2022): 108640. http://dx.doi.org/10.1016/j.jsat.2021.108640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Enyioha, Chineme, Graham W. Warren, Glen D. Morgan, and Adam O. Goldstein. "Tobacco Use and Treatment among Cancer Survivors." International Journal of Environmental Research and Public Health 17, no. 23 (December 6, 2020): 9109. http://dx.doi.org/10.3390/ijerph17239109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Leone, Frank T., Sarah Evers-Casey, Benjamin A. Toll, and Anil Vachani. "Treatment of Tobacco Use in Lung Cancer." Chest 143, no. 5 (May 2013): e61S-e77S. http://dx.doi.org/10.1378/chest.12-2349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Hatsukami, D. K., and R. G. Boyle. "Prevention and Treatment of Smokeless Tobacco Use." Advances in Dental Research 11, no. 3 (September 1997): 342–49. http://dx.doi.org/10.1177/08959374970110030601.

Full text

Abstract:

A review of the literature examining school-based prevention and treatment intervention programs for smokeless tobacco users is provided. Although few school-based prevention studies have been conducted, the results are promising. Many of the treatment studies that have been conducted, thus far, are limited due to the sample size and the lack of a control group. However, of the studies that have not had these limitations, the results are also promising. In general, studies show that intervention in the dental office can be effective and that group behavioral treatment may also improve cessation rates over minimal contact. On the other hand, pharmacological treatment, which has primarily focused on 2 mg nicotine gum, has not been found to be an effective treatment. Dentists are in an ideal position to advise and assist smokeless tobacco users to quit. The majority of smokeless tobacco users want advice and help from their dentists, and a significant number indicate that discussion of the negative oral effects from the use of smokeless tobacco has an impact on their desire to quit.

APA, Harvard, Vancouver, ISO, and other styles

12

Rosenthal, Abby C., Cathy L. Melvin, and Dianne C. Barker. "Treatment of Tobacco Use in Preconception Care." Maternal and Child Health Journal 10, S1 (August 1, 2006): 147–48. http://dx.doi.org/10.1007/s10995-006-0117-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Perka, Edward J. "Culture Change in Addictions Treatment." Health Promotion Practice 12, no. 6_suppl_2 (November 2011): 159S—165S. http://dx.doi.org/10.1177/1524839911414410.

Full text

Abstract:

Targeted training and technical assistance can have a major impact on the attitudes and beliefs of addiction service providers with respect to the treatment of tobacco dependency. Major gains have been made with the general public since the mid-1960s with respect to the reduction of tobacco use behavior and tobacco-related diseases. Tobacco use continues to be a major public health problem, and tobacco control initiatives are significantly affecting public attitudes and norms regarding tobacco use. There is, however, a specific population that has not benefited from these gains and, in fact, has been encouraged to continue smoking rather than make an attempt to quit. Individuals with a substance use disorder and/or mental health disorder have a much higher percentage of tobacco use than the general population, resulting in major health disparities. The addiction treatment and recovery community has lagged behind the general public in addressing tobacco use. New York State’s project, “Integrating Tobacco Use Interventions Into Chemical Dependence Services,” is a model that demonstrates how innovative regulations, and training and technical assistance developed specifically for addiction service providers, can initiate culture change with respect to tobacco use within addiction treatment settings, resulting in improved treatment outcomes and longer term stable recovery.

APA, Harvard, Vancouver, ISO, and other styles

14

Degenhardt, Louisa, Carolyn Coffey, John B. Carlin, Wendy Swift, Elya Moore, and George C. Patton. "Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia." British Journal of Psychiatry 196, no. 4 (April 2010): 290–95. http://dx.doi.org/10.1192/bjp.bp.108.056952.

Full text

Abstract:

BackgroundRegular adolescent cannabis use predicts a range of later drug use and psychosocial problems. Little is known about whether occasional cannabis use carries similar risks.AimsTo examine associations between occasional cannabis use during adolescence and psychosocial and drug use outcomes in young adulthood; and modification of these associations according to the trajectory of cannabis use between adolescence and age 20 years, and other potential risk factors.MethodA 10-year eight-wave cohort study of a representative sample of 1943 secondary school students followed from 14.9 years to 24 years.ResultsOccasional adolescent cannabis users who continued occasional use into early adulthood had higher risks of later alcohol and tobacco dependence and illicit drug use, as well as being less likely to complete a post-secondary qualification than non-users. Those using cannabis at least weekly either during adolescence or at age 20 were at highest risk of drug use problems in young adulthood. Adjustment for smoking in adolescence reduced the association with later educational achievement, but associations with drug use problems remained.ConclusionsOccasional adolescent cannabis use predicts later drug use and educational problems. Partial mediation by tobacco use raises a possibility that differential peer affiliation may play a role.

APA, Harvard, Vancouver, ISO, and other styles

15

Pbert, Lori, Jane Zapka, Denise G. Jolicoeur, Mary Jo White, Karin Valentine Goins, George Reed, and Judith K. Ockene. "Implementing State Tobacco Treatment Services." Health Promotion Practice 12, no. 6 (May 13, 2011): 802–10. http://dx.doi.org/10.1177/1524839910376035.

Full text

Abstract:

This case study was conducted between 2000 and 2003 to examine the implementation of community based tobacco treatment programs funded by the Massachusetts Department of Public Health Tobacco Control Program (MTCP). Four dimensions of implementation, drawn from several models of program evaluation are explored: (a) quantity of services, (b) quality of services, (c) implementation/use of systems, and (d) sustainability. The quantity of services delivered was high, reflecting MTCP’s focus on increasing availability of services, particularly in underserved populations. The quality of physician-delivered tobacco intervention did not meet national benchmarks for delivery of all 5As (Ask, Advise, Assess, Assist, Arrange follow-up) and only about half of organizations reported routine systems for auditing tobacco use documentation. Implementation of systems to identify tobacco users and deliver tobacco treatment varied widely by community health settings, with low rates of tobacco use documentation found. Finally, in an era of greater competition for scarce prevention dollars, sustainability of services over time must be planned for from the outset, as indicated by the success of programs that sustained services by proactively and creatively incorporating tobacco treatment into their organizations. This case study can inform states’ policies in their design of tobacco treatment services in community health settings.

APA, Harvard, Vancouver, ISO, and other styles

16

Shoenbill, Kimberly A., Eiman Newcomer, Celeslie Valcourt-Hall, Michael H. Baca-Atlas, Caleb A. Smith, and Adam O. Goldstein. "An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth." Nicotine & Tobacco Research 24, no. 5 (December 21, 2021): 794–98. http://dx.doi.org/10.1093/ntr/ntab233.

Full text

Abstract:

Abstract Introduction During the COVID-19 pandemic, many tobacco users increased their tobacco use, and calls to quitlines decreased. Among inpatients, the pandemic also necessitated a rapid transition of intensive tobacco use counseling to telehealth counseling. No data exist comparing the outcomes of telehealth inpatient counseling with in-person (pre-telehealth) counseling. Aims and Methods We examined inpatient data from a large tobacco treatment program (TTP) during two comparable time periods 04/01/2019–09/30/2019 (pre-telehealth) and 04/01/2020–09/30/2020 (telehealth). The pre-telehealth and telehealth populations were compared using Pearson’s chi-square test for homogeneity on each populations’ patient, visit, and medication acceptance characteristics. Reach to “current tobacco users” was analyzed using TTP flowsheet and electronic health record (EHR) data in relation to aggregate EHR data in the data warehouse. Results Mean monthly tobacco treatment inpatient counseling and outreach visits increased 38.9% in the telehealth period (M = 376, SD = 36.7) compared with the pre-telehealth period (M = 271, SD = 50.0) (t(10) = 3.8, p = .004). Reach significantly increased from 32.8% to 65.9% among all “current tobacco users” admitted, including 31.8% to 66.6% in races at higher risk for COVID-19 severe disease. Pearson’s chi-square tests for homogeneity showed significant differences in the pre-telehealth and telehealth population distributions for age, visit type, ethnicity, and medication acceptance. Conclusions This study offers the first understanding of characteristics of patients, visits, and medication acceptances in pre-telehealth and telehealth tobacco use treatment for inpatient populations. Larger reach and counseling were identified in the telehealth population. This study’s findings on inpatient tobacco use treatment can inform future reach and engagement of large numbers of patients who use tobacco products. Implications This study provides the first analysis of inpatient tobacco use treatment transition to telehealth delivery of care during the COVID-19 pandemic. The transition resulted in increases in reach and cessation counseling. These findings can inform efforts to improve reach, engagement, and research on telehealth delivery of inpatient tobacco use treatment.

APA, Harvard, Vancouver, ISO, and other styles

17

Falster, Kathleen, Linda Gelgor, Ansari Shaik, Iryna Zablotska, Garrett Prestage, Jeffrey Grierson, Rachel Thorpe, et al. "Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment." Sexual Health 5, no. 2 (2008): 141. http://dx.doi.org/10.1071/sh07082.

Full text

Abstract:

Objectives: To determine if there were any differences in antiretroviral treatment (ART) use across the three eastern states of Australia, New South Wales (NSW), Victoria and Queensland, during the period 1997 to 2006. Methods: We used data from a clinic-based cohort, the Australian HIV Observational Database (AHOD), to determine the proportion of HIV-infected patients on ART in selected clinics in each state and the proportion of treated patients with an undetectable viral load. Data from the national Highly Specialised Drugs program and AHOD were used to estimate total numbers of individuals on ART and the proportion of individuals living with HIV on ART nationally and by state. Data from the HIV Futures Survey and the Gay Community Periodic Survey were used to determine the proportion of community-based men who have sex with men on ART. The proportion of patients with primary HIV infection (PHI) who commenced ART within 1 year of diagnosis was obtained from the Acute Infection and Early Disease Research Program (AIEDRP) CORE01 protocol and Primary HIV and Early Disease Research: Australian Cohort (PHAEDRA) cohorts. Results: We estimated that the numbers of individuals on ART increased from 3181 to 4553 in NSW, 1309 to 1926 in Victoria and 809 to 1615 in Queensland between 2000 and 2006. However, these numbers may reflect a lower proportion of individuals living with HIV on ART in NSW compared with the other states (37% compared with 49 and 55% in 2000). We found similar proportions of HIV-positive men who have sex with men participants were on ART in all three states over the study period in the clinic-based AHOD cohort (81–92%) and two large, community-based surveys in Australia (69–85% and 49–83%). Similar proportions of treated patients had an undetectable viral load across the three states, with a consistently increasing trend over time observed in all states. We found that more PHI patients commenced treatment in the first year following HIV diagnosis in NSW compared with Victoria; however, the sample size was very small. Conclusions: For the most part, patterns of ART use were similar across NSW, Victoria and Queensland using a range of available data from cohort studies, community surveys and national prescription databases in Australia. However, there may be a lower proportion of individuals living with HIV on ART in NSW compared with the other states, and there is some indication of a more aggressive treatment approach with PHI patients in NSW compared with Victoria.

APA, Harvard, Vancouver, ISO, and other styles

18

Bloom, Erika Litvin, Michael V. Burke, Chris Kotsen, Adam O. Goldstein, Carol Ripley-Moffitt, Michael B. Steinberg, Mary Dailey, Laura E. Hunt, and Matthew P. Bars. "Billing Practices Among US Tobacco Use Treatment Providers." Journal of Addiction Medicine 12, no. 5 (2018): 381–86. http://dx.doi.org/10.1097/adm.0000000000000423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

de Dios, Marcel A., Ellen L. Vaughan, Cassandra A. Stanton, and Raymond Niaura. "Adolescent tobacco use and substance abuse treatment outcomes." Journal of Substance Abuse Treatment 37, no. 1 (July 2009): 17–24. http://dx.doi.org/10.1016/j.jsat.2008.09.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kalkhoran, Sara, Neal L. Benowitz, and Nancy A. Rigotti. "Reprint of: Prevention and Treatment of Tobacco Use." Journal of the American College of Cardiology 72, no. 23 (December 2018): 2964–79. http://dx.doi.org/10.1016/j.jacc.2018.10.020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sheffer, Christine E., Thomas Payne, Jamie S. Ostroff, Denise Jolicoeur, Michael Steinberg, Sharon Czabafy, Jonathan Foulds, Matthew Bars, Ken Wassum, and Barbara Perry. "Increasing the Quality and Availability of Evidence-based Treatment for Tobacco Dependence through Unified Certification of Tobacco Treatment Specialists." Journal of Smoking Cessation 11, no. 4 (December 30, 2014): 229–35. http://dx.doi.org/10.1017/jsc.2014.30.

Full text

Abstract:

Each year, tobacco use causes over 6 million deaths and is responsible for hundreds of billions of dollars in health care and economic costs in the world (WHO, 2011). If current trends continue, tobacco is expected to kill over 1 billion people in the 21st century, making it one of the single greatest causes of preventable death and disease in history (WHO, 2011). Long-term abstinence from tobacco use dramatically improves individuals’ health, reduces the incidence of tobacco-related disease, and is clearly responsible for saving lives (Anthonisen et al., 2005). Most tobacco users express a desire to achieve long-term abstinence from tobacco use and make numerous unsuccessful quit attempts over the course of many years (Borland, Partos, Yong, Cummings, & Hyland, 2012; CDC, 2011). Evidence-based treatments for tobacco use and dependence greatly improve the chances that quit attempts result in long-term abstinence (Chambless & Hollon, 1998; Chambless et al., 1998; Compas, Haaga, Keefe, Leitenberg, & Williams, 1998; Fiore et al., 2008; Zwar et al., 2004). Increasing the availability of high-quality evidence-based treatment for tobacco use and dependence will make it more likely that tobacco users use evidence-based treatments and that quit attempts translate into long-term abstinence. The professionalisation of treatment for tobacco dependence by the development of a rigorous, unified Tobacco Treatment Specialist (TTS) certification process will increase the availability of high-quality evidence-based treatment for tobacco use and dependence for all tobacco users.

APA, Harvard, Vancouver, ISO, and other styles

22

De los Reyes Nieto, Laura Roxana, Verónica Mireya Moreno Rodríguez, Ma Guadalupe Vázquez Salazar, María Guadalupe Esmeralda Vázquez Treviño, Sandra Angélica Ramírez Hernández, and Sanjuana de Jesús Ramos Luna. "Comportamiento del adolescente ante el consumo de tabaco / Behaviour of adolescent tobacco use." RICS Revista Iberoamericana de las Ciencias de la Salud 5, no. 10 (September 20, 2016): 51. http://dx.doi.org/10.23913/rics.v5i10.38.

Full text

Abstract:

El presente estudio describe el comportamiento del adolescente ante el consumo de tabaco, para lo cual se realizó un estudio descriptivo y correlacional a 250 estudiantes de una preparatoria de Ciudad Victoria, Tamaulipas, utilizando un instrumento integrado con sus datos personales, motivos de consumo e identificación de pros y contras. Los resultados muestran que la actitud del adolescente ante el consumo de tabaco es de rechazo generalizado, aunque no se descarta que existan algunos que sí lo acepten. La prevalencia de consumo es baja en este grupo debido a que se percibe como peligroso para la salud y el rendimiento físico. Se concluye que el adolescente está consciente de los efectos nocivos del tabaco y que aquellos que lo consumen lo hacen solamente como un medio para relajarse y bajar los niveles de estrés.

APA, Harvard, Vancouver, ISO, and other styles

23

Le, Kathy, Virmarie Correa-Fernández, Isabel Martinez Leal, Bryce Kyburz, Tzu-An Chen, Daniel Barrientos, Elma Saenz, et al. "Tobacco-free Workplace Program at a Substance Use Treatment Center." American Journal of Health Behavior 44, no. 5 (September 1, 2020): 652–65. http://dx.doi.org/10.5993/ajhb.44.5.9.

Full text

Abstract:

Objectives: About 65%-87% of substance use disorder patients smoke cigarettes, compared to 14% of the general adult population. Few substance use treatment centers (SUTCs) have comprehensive tobacco-free workplace (TFW) policies or offer tobacco interventions. Taking Texas Tobacco Free (TTTF) implements an evidence-based TFW program in SUTCs, including at the Billy T. Cattan Recovery Outreach Center (BTC). We present a mixed methods case study of BTC's TTTF implementation, success factors, and challenges. Methods: TTTF provided policy development assistance, training, treatment resources, and technical assistance over ∼9 months. Implementation was tailored using mixed methods. Quantitative data included surveys to stakeholders (Nmax = 7), a pre- and post-training questionnaire assessing knowledge gain, and reported quantities of tobacco use assessments (TUAs) administered and nicotine replacement therapy (NRT) provided. Qualitative data included stakeholder focus groups and interviews (18 participants). Results: All employees reported TFW policy compliance. Employees exhibited a 20% knowledge gain. Clinicians increased self-report of NRT provision and tobacco cessation counseling. During implementation, BTC administered TUAs to 171 patients and dispensed NRT to 70 of 110 tobacco-using patients. Conclusion: Qualitative findings contextualized quantitative outcomes. TTTF implementation changed clinician attitudes, knowledge, and practices regarding tobacco treatment, facilitating patient quit attempts.

APA, Harvard, Vancouver, ISO, and other styles

24

Lee, Dustin C., Alan J. Budney, Mary F. Brunette, John R. Hughes, Jean-Francois Etter, and Catherine Stanger. "Treatment models for targeting tobacco use during treatment for cannabis use disorder: Case series." Addictive Behaviors 39, no. 8 (August 2014): 1224–30. http://dx.doi.org/10.1016/j.addbeh.2014.04.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Hays, J. Taylor, Ivana T. Croghan, Darrell R. Schroeder, Michael V. Burke, Jon O. Ebbert, David D. McFadden, and Richard D. Hurt. "Residential Treatment Compared With Outpatient Treatment for Tobacco Use and Dependence." Mayo Clinic Proceedings 86, no. 3 (March 2011): 203–9. http://dx.doi.org/10.4065/mcp.2010.0703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Richter, Kimber P., Jamie J. Hunt, A. Paula Cupertino, Susan Garrett, and Peter D. Friedmann. "Understanding the drug treatment community's ambivalence towards tobacco use and treatment." International Journal of Drug Policy 23, no. 3 (May 2012): 220–28. http://dx.doi.org/10.1016/j.drugpo.2011.11.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

McDaniel, Anna M., Renee M. Stratton, and Maria Britain. "Systems Approaches to Tobacco Dependence Treatment." Annual Review of Nursing Research 27, no. 1 (December 2009): 345–63. http://dx.doi.org/10.1891/0739-6686.27.345.

Full text

Abstract:

Nurses have been at the forefront of initiatives to improve patient outcomes through systems change. Nursing research addressing systems approaches to treatment of tobacco dependence has demonstrated increased implementation of evidence-based practice guidelines. Existing health system research conducted by nurse scientists has focused on four strategies: tobacco use identification systems, education and training of nursing staff to deliver tobacco intervention, dedicated staff for tobacco dependence treatment in both acute and primary care settings, and institutional policies to support tobacco intervention. Nursing involvement in multidisciplinary health services research focusing on tobacco treatment has lagged behind advances in clinical nursing research of individual-focused smoking cessation interventions. Health information technology shows promise as part of an integrated approach to systems changes to support tobacco intervention, particularly in light of the current national emphasis on adoption and meaningful use of electronic health records. Future directions for translational research present unprecedented opportunity for nurse scientists to respond to the call for policy and systems changes to support tobacco treatment.

APA, Harvard, Vancouver, ISO, and other styles

28

Ebbert, Jon O., and Karl Fagerstrom. "Pharmacological Interventions for the Treatment of Smokeless Tobacco Use." CNS Drugs 26, no. 1 (January 2012): 1–10. http://dx.doi.org/10.2165/11598450-000000000-00000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Prochaska, Judith J., Patricia Gill, and Sharon M. Hall. "Treatment of Tobacco Use in an Inpatient Psychiatric Setting." Psychiatric Services 55, no. 11 (November 2004): 1265–70. http://dx.doi.org/10.1176/appi.ps.55.11.1265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Clawson, Ashley H., Jody S. Nicholson, Michael J. McDermott, James L. Klosky, and Vida L. Tyc. "Tobacco Use and Exposure Among Youth Undergoing Cancer Treatment." Journal of Pediatric Health Care 29, no. 1 (January 2015): 80–87. http://dx.doi.org/10.1016/j.pedhc.2014.07.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Ebbert, Jon O., Lowell C. Dale, Kristin S. Vickers, Thomas R. Gauvin, Nadene E. Bunge, and Richard D. Hurt. "Residential treatment for smokeless tobacco use: A case series." Journal of Substance Abuse Treatment 26, no. 4 (June 2004): 261–67. http://dx.doi.org/10.1016/j.jsat.2004.01.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

McClure, Erin A., Rachel A. Rabin, Dustin C. Lee, and Chandni Hindocha. "Treatment Implications Associated With Cannabis and Tobacco Co-use." Current Addiction Reports 7, no. 4 (October 2, 2020): 533–44. http://dx.doi.org/10.1007/s40429-020-00334-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dale, Lowell C., Jon O. Ebbert, Elbert D. Glover, Ivana T. Croghan, Darrell R. Schroeder, Herbert H. Severson, and Richard D. Hurt. "Bupropion SR for the treatment of smokeless tobacco use." Drug and Alcohol Dependence 90, no. 1 (September 2007): 56–63. http://dx.doi.org/10.1016/j.drugalcdep.2007.02.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Ebbert, Jon, Lowell Dale, Herbert Severson, Ivana Croghan, Donna Rasmussen, Darrell Schroeder, Mark W. Vander Weg, and Richard Hurt. "Nicotine lozenges for the treatment of smokeless tobacco use." Nicotine & Tobacco Research 9, no. 2 (2007): 233–40. http://dx.doi.org/10.1080/14622200601080349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Guydish, Joseph, Thao Le, Sindhushree Hosakote, Elana Straus, Jessie Wong, Cristina Martínez, and Kevin Delucchi. "Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients." Journal of Substance Abuse Treatment 132 (January 2022): 108496. http://dx.doi.org/10.1016/j.jsat.2021.108496.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lee, Dustin C., Denise D. Walker, John R. Hughes, Mary F. Brunette, Emily Scherer, Catherine Stanger, Jean-Francois Etter, Samantha Auty, and Alan J. Budney. "Sequential and simultaneous treatment approaches to cannabis use disorder and tobacco use." Journal of Substance Abuse Treatment 98 (March 2019): 39–46. http://dx.doi.org/10.1016/j.jsat.2018.12.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Warner, David O. "Anesthesiologists and the Other Pandemic: Tobacco Use." Anesthesiology 137, no. 4 (September 23, 2022): 484–508. http://dx.doi.org/10.1097/aln.0000000000004346.

Full text

Abstract:

Tobacco use will kill a projected 1 billion people in the 21st century in one of the deadliest pandemics in history. Tobacco use disorder is a disease with a natural history, pathophysiology, and effective treatment options. Anesthesiologists can play a unique role in fighting this pandemic, providing both immediate (reduction in perioperative risk) and long-term (reduction in tobacco-related diseases) benefits to their patients who are its victims. Receiving surgery is one of the most powerful stimuli to quit tobacco. Tobacco treatments that combine counseling and pharmacotherapy (e.g., nicotine replacement therapy) can further increase quit rates and reduce risk of morbidity such as pulmonary and wound-related complications. The perioperative setting provides a great opportunity to implement multimodal perianesthesia tobacco treatment, which combines multiple evidence-based tactics to implement the four core components of consistent ascertainment and documentation of tobacco use, advice to quit, access to pharmacotherapy, and referral to counseling resources.

APA, Harvard, Vancouver, ISO, and other styles

38

Ganhao, I., M. Trigo, and A. Paixao. "Co-use of tobacco and cannabis: Complicated partnerships." European Psychiatry 64, S1 (April 2021): S575. http://dx.doi.org/10.1192/j.eurpsy.2021.1534.

Full text

Abstract:

IntroductionTreating addiction is more challenging when there are co-addictions. Tobacco smoking is commonly associated with substance abuse, alcohol use disorders, excessive caffeine intake and pathological gambling among other addictions. Smoking reduction and cessation programmes´ objectives benefit from interventions targeting co-addictions.ObjectivesDifficulties arising from smoking reduction and cessation in the context of co-use of cannabis prompt literature review and reflection of a smoking cessation programme team.MethodsPubmed and Google Scholar literature search using terms smoking cessation / tobacco cessation and cannabis.ResultsCo-use of tobacco and cannabis is: 1) very common, 2) associated with greater prevalence of morbidity and social problems, 3) associated with greater dependence of the other substances, 4) negatively influences quit outcomes of either, 5) increases the risk of relapse. Co-users are more likely to perceive the harmful effects of tobacco, have greater motivation and are more likely to quit tobacco than cannabis, which may be perceived as low risk. Treatment of either tobacco smoking or cannabis use may lead to compensatory increase in use of the other substance. There is a significant lack of literature on co-use treatment strategies.ConclusionsCo-use of tobacco and cannabis makes cessation and relapse prevention of either addiction more difficult and should be taken into account in smoking reduction and cessation programmes and in cannabis treatment interventions. Treatment targetting both tobacco and cannabis use, either simultaneously or sequentially, is likely more successful than interventions targeting only either one. Much remais to be studied on how to treat co-use of tobacco and cannabis.

APA, Harvard, Vancouver, ISO, and other styles

39

Rojewski, Alana M., Steffani R. Bailey, Steven L. Bernstein, Nina A. Cooperman, Ellen R. Gritz, Maher A. Karam-Hage, Megan E. Piper, Nancy A. Rigotti, and Graham W. Warren. "Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States." Nicotine & Tobacco Research 21, no. 11 (June 15, 2018): 1453–61. http://dx.doi.org/10.1093/ntr/nty123.

Full text

Abstract:

Abstract The Comorbidity Workgroup of the Tobacco Treatment Research Network, within the Society for Research on Nicotine and Tobacco, previously highlighted the need to provide tobacco treatment to patients diagnosed with comorbid physical and mental health conditions. Yet, systemic barriers in the United States health care system prevent many patients who present for medical treatment from getting the evidence-based tobacco treatment that they need. The identified barriers include insufficient training in the epidemiologic impact of tobacco use, related disorders, and pharmacological and behavioral treatment approaches; misunderstanding among clinicians about the effectiveness of tobacco treatment; lack of therapeutic support from clinical staff; insufficient use of health information technology to improve tobacco use identification and treatment; and limited time and reimbursement for clinicians to provide treatment. We highlight three vignettes demonstrating the complexities of practical barriers at the health care system level. We consider each of the barriers in turn and discuss evidence-based strategies that could be implemented in the clinical care of patients with comorbid conditions. In addition, in the absence of compelling data to guide implementation approaches, we offer suggestions for potential strategies and avenues for future research. Implications: Three vignettes highlighted in this article illustrate some systemic barriers to providing tobacco treatment for patients being treated for comorbid conditions. We explore the barriers to tobacco treatment and offer suggestions for changes in training, health care systems, clinical workflow, and payment systems that could enhance the reach and the quality of tobacco treatment within the US health care system.

APA, Harvard, Vancouver, ISO, and other styles

40

Okoli, Chizimuzo T. C., and Sarret Seng. "Correlates of Tobacco Use and Consumption Among Hospitalized Psychiatric Patients." Western Journal of Nursing Research 41, no. 8 (January 18, 2019): 1121–36. http://dx.doi.org/10.1177/0193945918823483.

Full text

Abstract:

Using a cross-sectional analysis, we assessed correlates of tobacco use and tobacco consumption from inpatient records ( N = 2,060) from a state psychiatric hospital. We used multivariate logistic regression analyses to examine correlates of tobacco use in the total sample and multivariate linear regression to examine correlates of tobacco consumption among tobacco users. Tobacco-use associated variables in the total sample were being male, being White, lower education, having a substance-use disorder/treatment, having an externalizing or psychotic disorder, being from a rural county, being younger, and shorter length of hospital stay. Among tobacco users ( n = 1,153), correlates of amount of tobacco consumption were being male; being White; lower education; having an internalizing, externalizing, and psychotic disorder; using cigarettes; and living in a county without a smoke-free policy. Psychiatric patients should be screened for specific associative variables as part of tobacco-use assessments. Future research may expand on the current findings to develop strategies to enhance tobacco treatment among psychiatric patients.

APA, Harvard, Vancouver, ISO, and other styles

41

Warren, Graham W., Jamie S. Ostroff, and John R. Goffin. "Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco." American Society of Clinical Oncology Educational Book, no. 36 (May 2016): 223–29. http://dx.doi.org/10.1200/edbk_158704.

Full text

Abstract:

Tobacco use is the largest preventable risk factor for the development of several cancers, and continued tobacco use by patients with cancer and survivors of cancer causes adverse outcomes. Worldwide tobacco control efforts have reduced tobacco use and improved health outcomes in many countries, but several countries continue to suffer from increased tobacco use and associated adverse health effects. Continued tobacco use by patients undergoing cancer screening or treatment results in continued risk for cancer-related and noncancer-related health conditions. Although integrating tobacco assessment and cessation support into lung cancer screening and cancer care is well justified and feasible, most patients with cancer unfortunately do not receive evidence-based tobacco cessation support. Combining evidence-based methods of treating tobacco addiction, such as behavioral counseling and pharmacotherapy, with practical clinical considerations in the setting of lung cancer screening and cancer treatment should result in substantial improvements in access to evidence-based care and resultant improvements in health risks and cancer treatment outcomes.

APA, Harvard, Vancouver, ISO, and other styles

42

Pacek, Lauren R., Andrea C. Villanti, and F. Joseph Mcclernon. "Not Quite the Rule, But No Longer the Exception: Multiple Tobacco Product Use and Implications for Treatment, Research, and Regulation." Nicotine & Tobacco Research 22, no. 11 (December 2, 2019): 2114–17. http://dx.doi.org/10.1093/ntr/ntz221.

Full text

Abstract:

Abstract The patterns of tobacco product use in the United States have changed during the past several decades. Currently, a large proportion of tobacco users report using multiple tobacco products (MTPs). The prevalence of MTP use varies significantly by cigarette smoking frequency, as well: nearly half (46.9%) of all non-daily smokers report using other tobacco products within the past 30 days. Despite this, much of extant tobacco dependence treatment efforts, tobacco regulatory science research, and tobacco product research, in general, has focused largely on single product use (ie, cigarette smoking). To effectively design interventions and model the potential impact of regulations on tobacco products aimed at reducing tobacco use, as well as effectively study tobacco users, it is essential to consider actual use patterns in the population of tobacco users. Implications: MTP use is increasingly common in the United States. This commentary highlights the impact that MTP use has for efforts to treat tobacco dependence, tobacco regulatory science efforts, as well as on tobacco research, in general.

APA, Harvard, Vancouver, ISO, and other styles

43

Samaha, Hannah L., Virmarie Correa-Fernández, Cho Lam, William T. Wilson, Bryce Kyburz, Tim Stacey, Teresa Williams, and Lorraine R. Reitzel. "Addressing Tobacco Use Among Consumers and Staff at Behavioral Health Treatment Facilities Through Comprehensive Workplace Programming." Health Promotion Practice 18, no. 4 (March 7, 2017): 561–70. http://dx.doi.org/10.1177/1524839917696713.

Full text

Abstract:

Tobacco use is the leading cause of death and disability in the United States; cigarette smoking is the most common form of tobacco use. Smoking has become increasingly concentrated among individuals with behavioral health needs (e.g., persistent mental illness) and has led to increased morbidity and mortality in this group relative to the general population. Comprehensive tobacco-free workplace programs are effective in reducing tobacco use and cigarette smoke exposure among behavioral health consumers and the individuals who serve them. Taking Texas Tobacco-Free (TTTF) represents an academic–community partnership formed to address tobacco use among consumers and employees at behavioral health clinics across Texas via the dissemination of an evidence-based, multicomponent tobacco-free workplace program. Program components of TTTF include tobacco-free campus policy implementation and enforcement, staff education about tobacco use hazards, provider training to regularly screen for and address tobacco dependence via intervention, and community outreach. These components, the nature of the academic–community partnership, the process of behavioral health facility involvement and engagement, and the benefits and challenges of implementation from the perspectives of the project team and participating clinic leaders are described. This information can guide similar academic and community partnerships and inform the implementation of other statewide tobacco-free workplace programming.

APA, Harvard, Vancouver, ISO, and other styles

44

Nguyen, Nam, Trang Nguyen, Van Truong, Kim Dang, Nina Siman, and Donna Shelley. "Impact of a tobacco cessation intervention on adherence to tobacco use treatment guidelines among village health workers in Vietnam." Global Health Promotion 27, no. 3 (July 18, 2019): 24–33. http://dx.doi.org/10.1177/1757975919854032.

Full text

Abstract:

Community health workers (in Vietnam referred to as village health workers) have the potential to play a key role in expanding access to evidence-based tobacco use treatment. We conducted a cluster randomized controlled trial in community health centers in Vietnam that compared the effect of provider advice and cessation assistance (i.e. brief counseling and patient education materials) (BC) vs. BC + three sessions of in-person counseling delivered by a village health worker (BC+R) on providers’ and village health workers’ adherence to tobacco use treatment guidelines. All village health workers and health care providers received training. This paper presents data on the effect of the intervention on village health workers’ adherence to tobacco use treatment guidelines, including asking about tobacco use, advising smokers to quit, offering assistance and their attitude, norms, and self-efficacy related to tobacco use treatment. We examined changes in adherence to tobacco use treatment guidelines before and 12 months after the intervention among 89 village health workers working in the 13 community health centers enrolled in the BC+R study condition. Village health workers’ adherence to tobacco use treatment guidelines increased significantly. Village health workers were more likely to ask about tobacco use (3.4% at baseline, 32.6% at 12 months), offer advice to quit (4.5% to 48.3%) and offer assistance (1.1% to 38.2%). Perceived barriers to treating tobacco use decreased significantly. Self-efficacy and attitudes towards treating tobacco use improved significantly. Increased adherence to tobacco use treatment guidelines was associated with positive attitudes towards their role in delivering tobacco use treatment and increasing awareness of the community health center smoke-free policy. The findings suggest that, with training and support systems, village health workers can extend their role to include smoking cessation services. This workforce could represent a sustainable resource for supporting smokers who wish to quit.

APA, Harvard, Vancouver, ISO, and other styles

45

Kumari, Laxmi, and Sandhya Gupta. "Tobacco use and Smoking among patients undergoing treatment of Cancer”." Indian Journal of Psychiatric Nursing 15, no. 1 (2018): 53. http://dx.doi.org/10.4103/2231-1505.262508.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Na, Euihyeon, and Sungwon Roh. "Treatment of Tobacco Use Disorders in People with Mental Illness." Journal of the Korean Society for Research on Nicotine and Tobacco 6, no. 2 (July 15, 2015): 78–85. http://dx.doi.org/10.25055/jksrnt.2015.6.2.78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Hayes, Kim A., Lindsay T. Olson, Elizabeth M. Brown, Haven B. Battles, and Harlan R. Juster. "Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use." Preventive Medicine Reports 24 (December 2021): 101509. http://dx.doi.org/10.1016/j.pmedr.2021.101509.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Cerimele, J. M., A. C. Halperin, and A. J. Saxon. "Tobacco Use Treatment in Primary Care Patients with Psychiatric Illness." Journal of the American Board of Family Medicine 27, no. 3 (May 1, 2014): 399–410. http://dx.doi.org/10.3122/jabfm.2014.03.130252.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Waller, Lynsay L., Kathryn E. Weaver, W. Jeffrey Petty, and Antonius A. Miller. "Effects of continued tobacco use during treatment of lung cancer." Expert Review of Anticancer Therapy 10, no. 10 (October 2010): 1569–75. http://dx.doi.org/10.1586/era.10.140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

DiLorenzo, Thomas M., Thomas G. Kern, and Rosann M. Pieper. "Treatment of smokeless tobacco use through a formalized cessation program." Behavior Therapy 22, no. 1 (1991): 41–46. http://dx.doi.org/10.1016/s0005-7894(05)80242-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!